Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.

Bacterial response at the test of cure visit and at the FU visit 28 to 42 days after last dose of study medication

Time frame: visit 28 to 42 days after last dose

Clinical response at during-treatment visit (Day 4-7) and at follow-up 28 to 42 days after last dose

Time frame: (Day 4-7) and at follow-up 28 to 42 days after last dose

Reduction from baseline in pain report at the different assessment visits

Time frame: Over the entire trial period (overall)

Necessity for modifying antibiotic therapy at the during-treatment visit and TOC visit and necessity for institution of an antibiotic therapy at follow-up

Time frame: Over the entire trial period (overall)